Surgery for Cancer: A Trigger for Metastases.
Samer Tohme1, Richard L Simmons1, Allan Tsung2
1Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania.
Cancer Research
|March 24, 2017
Summary
Surgery can trigger cancer recurrence by promoting metastasis and suppressing immunity during the perioperative period. Understanding these effects may lead to new treatments to improve long-term cancer outcomes.
Area of Science:
- Oncology
- Surgical Oncology
- Cancer Biology
Background:
- Surgery is a critical cancer treatment offering curative potential.
- The perioperative period presents risks for micrometastatic disease progression and new metastasis formation.
- The precise impact of surgery on cancer recurrence remains incompletely understood.
Purpose of the Study:
- To review clinical and experimental evidence linking surgery and inflammation to cancer recurrence.
- To explore how surgical trauma and perioperative factors influence metastatic processes.
- To suggest novel therapeutic strategies targeting the perioperative window for improved oncological outcomes.
Main Methods:
- Systematic review of existing clinical and experimental literature.
- Analysis of mechanisms by which surgery promotes cancer cell shedding, immune suppression, and metastasis.
- Examination of the role of inflammation and perioperative factors (anesthesia, transfusions, hypothermia, complications) in disease recurrence.
Main Results:
- Surgery increases cancer cell shedding and suppresses anti-tumor immunity.
- Surgical trauma triggers inflammatory responses that can accelerate micrometastatic growth.
- Perioperative factors like anesthesia and hypothermia may also contribute to early recurrence.
Conclusions:
- Surgery can create a protumorigenic environment, increasing the risk of cancer recurrence.
- Targeting the inflammatory and immune-modulating effects of surgery is a potential therapeutic avenue.
- Further research is needed to develop strategies that mitigate perioperative risks and improve long-term cancer survival.
Related Concept Videos
Metastasis
6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer
55.2K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
55.2K
Skin Cancer
6.4K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
6.4K
Mitogens and the Cell Cycle
8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
The Tumor Microenvironment
8.0K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
8.0K


